GEN-MKT-18-7897-A
Jan 14, 2019 | Blogs, Food / Beverage | 0 comments
Part 1: Cannabis is Legal in Canada – How Did We Get Here? Part 2: Canada’s Focus on Cannabis Quality and Safety Intensifies
Welcome to the third in a series of blogs from the cannabis team at SCIEX, designed to bring you up to speed and put you in the lead of the recently legalized cannabis market in Canada.
‘Protecting public health and safety by allowing adults access to legal cannabis’ is high on Health Canada’s agenda. In the last blog, we explored the tests involved in ensuring legal cannabis is safe, here we will examine the technology behind these tests.
What the Analytical Testing Lab Needs to KnowWhether cultivation, processing, analyzing or selling, anyone planning to operate in the market must be a cannabis license holder under the Act. Legal cannabis products must be produced within the rules of the law and undergo rigorous testing before they can be made available to the public.
Regulatory standards for cannabis testing are expected to evolve, and it would be fair to say that the cannabis testing landscape is not only uncertain, but it is complex. Here’s a quick rundown on where things stand at the time of writing this blog:
With the challenges outlined above, the question is:
What Techniques Best Suit These Testing Demands?Labs need the right instruments and methods to stay ahead of regulation, keep up with demand and deliver fast and reliable results – better than the competition. We believe this can be achieved with the most advanced technologies that offer high-throughput validated methods for accurate results, with complete workflows that combine tests into a single analysis.
The industry is now turning to instruments that are proven in more established applications, such as food and pharma, and have already been applied to cannabis testing with great success. High-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) is one of these technologies.
Cannabis has historically been monitored by gas chromatography-mass spectrometry (GC-MS) requiring complicated sample preparation with derivatization and relatively long sample run times. LC-MS/MS has now emerged as one of the most reliable and robust high-throughput analytical methods available, tackling the demands of cannabis testing head on.
How We Can HelpSCIEX offers everything licensed analytical testing labs, regulatory laboratories, and licensed producers need to perform a wide variety of tests to Health Canada standards while cutting tests down to record time.
We have pioneered standardized testing methods that enable you to overcome the complex analytical nature of cannabis in regulated markets. Best-in-class LC-MS/MS technology has been applied to potency, terpene, pesticide, and contaminant analysis, allowing you to match all chemical residues to the lower possible limit, within a single instrument. Users experience superior selectivity, sensitivity, and ruggedness without extensive sample preparation.
To help your lab meet demand and get ahead of new regulations, we have put together an exclusive free cannabis testing info kit packed with useful information, including methods and solutions to common screening challenges.
Fill out the form on your right to download the info kit, and take the first step towards fast, accurate, and compliant cannabis testing.
Produced by certain moulds, thriving in crops such as grain, nuts and coffee, mycotoxins have contaminated agriculture and food production industries for a long time. To intensify the challenge, mycotoxins are resilient, not easily broken down and ensuring the safety of food supply chains requires comprehensive solutions and we are here to share those solutions with you.
Electron-Activated Dissociation (EAD) is transforming the fields of metabolomics and lipidomics by providing enhanced fragmentation techniques that offer deeper insights into molecular structures. In September, Technology Networks hosted a webinar, “Enhancing Mass-Based Omics Analysis in Model Organisms,” featuring Dr. Valentina Calabrese from the Institute of Analytical Sciences at the University of Lyon. Valentina shared her insights on improving omics-based mass spectrometry analysis for toxicology studies using model organisms, particularly in metabolomics and lipidomics. This blog explores the additional functionalities EAD offers, its benefits in untargeted workflows, its incorporation into GNPS and molecular networking, and the future role it could play in these scientific domains.
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) has gained significant attention in the clinical laboratory due to its ability to provide best-in-class sensitivity and specificity for the detection of clinically relevant analytes across a wide range of assays. For clinical laboratories new to LC-MS/MS, integrating this technology into their daily routine operations may seem like a daunting task. Developing a clear outline and defining the requirements needed to implement LC-MS/MS into your daily operations is critical to maximize the productivity and success of your clinical laboratory.
Posted by
You must be logged in to post a comment.
Share this post with your network